Our Team

Founding Scientists and Management

"JACK" Jiagang Zhao, PhD, Founder, CEO, and Board Member

Dr. Zhao previously held a faculty position at Shiley Eye Institute of University of California San Diego.
Dr. Zhao worked as a scientist with a leadership role in Tularik (acquired by Amgen) and Anadys Pharmaceuticals (acquired by Roche).
Dr. Zhao completed his graduate work at Icahn School of Medicine at Mount Sinai and subsequently received his postdoctoral training in molecular neurobiology at Salk Institute.  

Ying Wu, MD, Co-founder, Vice President, and Board Member

Dr. Wu has over 27 years of biomedical research and drug discovery experience in academia and industry, including The Scripps Research Institute, University of California San Diego, Pfizer, and Johnson & Johnson.

Dr. Wu obtained her MD and clinical training from Bethune Medical Science University in China.  After moving to United States, she invented in vitro coupled transcription and translation system at Public Health Research Institute in New York City.  She also worked with AIDS research pioneer Dr. David Ho at Aaron Diamond AIDS Research Center in New York before coming to San Diego.  

Peng Cheng, PhD, Board Member

Dr. Peng Cheng is the Managing Partner of SV Tech Ventures.

Peng was most recently Founder and Managing Director of Brilliance Capital, a venture capital company focusing on investment in early-stage technology companies, ranging from networking, wireless, semiconductor, and biotech. Prior to that, he was the senior manager at Intel from 1990 to 2001, where he was involved in research and development of deep sub-micron device and processing, Silicon-on-Insulator, spacer gate, and Micro-Electro-Mechanical System (MEMS). He is the holder of more than 30 U.S. patents.

Dr. Cheng received his Ph.D. in Physics from Stanford University in 1990 & B.S. in Physics from Peking University in 1985.

Guo-Liang Yu, Ph.D. Advisor, former Board Member

Dr. Guo-Liang Yu is a co-founder and CEO of Apollomics, Inc. He is a venture partner at Orbimed and the Executive Chairman of Crown Bioscience.
Dr. Yu co-founded Epitomics Inc., an antibody-based Biotechnology Company recently acquired by Abcam at $170 M. He served as Chairman, President and CEO of Epitomics Inc. for 10 years.

Yajun Xu, PhD, Board Member

Yajun Xu is currently president of Shangpharma Investment Group.  She also serves as Sr. advisor for Shangbay Capital, co-founder (Epimab Inc.), board member and advisor on numerus biotech companies in U.S. and China. Previously, she was Sr. vice president of corporate development of Shangpharma, executive vice president of biology and preclinical service at Chempartner in Shanghai, China. Before Joining Shangpharma, Yajun was director of inflammation at Millennium pharma Inc. and senior scientist at BASF Bioresearch Corp. (now AbbVie Bioresearch Corp.). She received her Ph.D. in Biochemistry at Brandeis University and postdoctoral training at Harvard School of Public Health.

Natalie Afshari M.D., F.A.C.S., Adviser

Dr. Afshari is Professor of Ophthalmology and holds Stuart I. Brown MD Chair in Ophthalmology in Memory of Donald P. Shiley at the Shiley Eye Institute of University of California San Diego.

Nancy Chang, PhD, Advisor

Dr. Chang is CEO and Chairperson of Ansun.  She previously was the Co-founder and Chairman of Tanox (acquired by Genentech in 2007).

Hong Qi, PhD, Advisor

Recently he was Vice President of Product Development at Xeris Pharmaceuticals.  Before, he was Vice President at Otonomy and Senior Director at Amylin (Wholly owned subsidiary of BMS and AstraZeneca). He has a proven record of two NDA approvals and one BLA approval.

Connect with us

10355 Science Center Drive, Suite 130, San Diego, CA 92121

  • dummy info@alpinebt.com

Newsletter

Enter your email and we'll send you more information

Search